5.96
前日終値:
$5.95
開ける:
$6
24時間の取引高:
1.07M
Relative Volume:
0.57
時価総額:
$523.54M
収益:
$30.91M
当期純損益:
$-209.47M
株価収益率:
-1.7909
EPS:
-3.3279
ネットキャッシュフロー:
$-147.13M
1週間 パフォーマンス:
+9.16%
1か月 パフォーマンス:
+5.86%
6か月 パフォーマンス:
-26.96%
1年 パフォーマンス:
-14.98%
Verastem Inc Stock (VSTM) Company Profile
Compare VSTM vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
VSTM
Verastem Inc
|
5.96 | 523.54M | 30.91M | -209.47M | -147.13M | -3.3279 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Verastem Inc Stock (VSTM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-12 | 再開されました | BTIG Research | Buy |
| 2026-02-04 | 開始されました | H.C. Wainwright | Buy |
| 2025-10-16 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-04-10 | 開始されました | Jefferies | Buy |
| 2025-03-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-12-31 | 繰り返されました | BTIG Research | Buy |
| 2024-09-30 | 開始されました | Guggenheim | Buy |
| 2023-11-21 | 再開されました | BTIG Research | Buy |
| 2023-09-27 | 開始されました | B. Riley Securities | Buy |
| 2023-06-15 | アップグレード | Mizuho | Neutral → Buy |
| 2022-09-07 | 再開されました | Alliance Global Partners | Buy |
| 2022-04-29 | 再開されました | Cantor Fitzgerald | Overweight |
| 2022-04-14 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-03-09 | 開始されました | Truist | Buy |
| 2021-07-01 | 開始されました | Alliance Global Partners | Buy |
| 2021-05-24 | アップグレード | BTIG Research | Neutral → Buy |
| 2019-06-20 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-05-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2018-07-13 | 開始されました | BTIG Research | Buy |
| 2018-05-02 | 開始されました | Seaport Global Securities | Buy |
| 2018-03-08 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-09-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-13 | 開始されました | Oppenheimer | Outperform |
| 2017-03-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-09-29 | ダウングレード | Cantor Fitzgerald | Buy → Hold |
| 2015-09-29 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-09-29 | ダウングレード | Jefferies | Buy → Hold |
| 2015-09-29 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2015-09-28 | ダウングレード | Mizuho | Buy → Neutral |
| 2015-09-28 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-05-12 | 繰り返されました | UBS | Buy |
| 2015-04-08 | 開始されました | H.C. Wainwright | Buy |
| 2015-01-23 | 繰り返されました | ROTH Capital | Buy |
| 2014-07-08 | 再開されました | Oppenheimer | Perform |
| 2014-02-11 | 開始されました | Mizuho | Buy |
すべてを表示
Verastem Inc (VSTM) 最新ニュース
MSN Money - MSN
Earnings Preview: Verastem to Report Financial Results on May 07 - Moomoo
Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer - BioSpace
Verastem (VSTM) Launches Campaign for Recurrent Low-Grade Serous Ovarian Cancer - GuruFocus
KRAS-mutated LGSOC campaign debuts as Verastem, Inc. targets patient support - Traders Union
Verastem (VSTM) Projected to Post Earnings on Thursday - MarketBeat
Mizuho Securities Adjusts Verastem Price Target to $16 From $18, Maintains Outperform Rating - marketscreener.com
CapEx per share of Verastem, Inc. – MUN:2VSA - TradingView
Verastem to Present at the 8th Annual JMP Securities Healthcare Conference - AOL.com
Liquidity Mapping Around (VSTM) Price Events - Stock Traders Daily
Verastem Oncology announces management changes - MSN
VSTM Price Today: Verastem, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Verastem, Inc. (NASDAQ:VSTM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
VSTM Reiterated by BTIG -- Price Target Maintained at $19.00 - GuruFocus
Torray Investment Partners LLC Purchases Shares of 216,387 Verastem, Inc. $VSTM - MarketBeat
Verastem, Inc. sets first quarter earnings call for May 7 at 4:30pm ET - Traders Union
Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026 - ChartMill
VSTM Technical Analysis | Trend, Signals & Chart Patterns | VERASTEM INC (NASDAQ:VSTM) - ChartMill
Verastem Inc stock (US92335V1008): Is its oncology pipeline strong enough to unlock biotech upside? - AD HOC NEWS
BTIG Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $19 - Moomoo
Verastem's (VSTM) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Verastem (NASDAQ:VSTM) Trading Down 4.1%Here's Why - MarketBeat
Verastem (VSTM) Stock Growth Drivers (Momentum Fading) 2026-04-20Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Vectoring In On Verastem (NASDAQ:VSTM) - Seeking Alpha
Verastem Inc stock (US92335V1008): Is its cancer therapy pipeline strong enough to unlock new upside - AD HOC NEWS
Verastem (VSTM) Stock: Cheap or Expensive (+3.79%) 2026-04-18Social Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Verastem (VSTM) Stock: Is It a Strong Buy? (Extends Gains) 2026-04-18Trend Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Verastem, Inc. (VSTM) Stock Analysis: 158% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
VSTM Stock Chart | VERASTEM INC (NASDAQ:VSTM) - ChartMill
Why (VSTM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Q4 2025 Verastem Inc Earnings Call Transcript - GuruFocus
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results - Eastern Progress
PI3K Inhibitor Drug Class Market (2026-2033) | PI3Kα, PI3Kβ, - openPR.com
Chipmakers Recap: How is Verastem Inc managing supply chain issues2026 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
Verastem (NASDAQ:VSTM) Trading Up 7.6%What's Next? - MarketBeat
Aug Wrap: What analysts say about Verastem Inc stock2026 Bull vs Bear & Weekly High Return Forecasts - baoquankhu1.vn
H.C. Wainwright reiterates Verastem stock rating on durable trial data By Investing.com - Investing.com Canada
Is momentum building in Verastem (VSTM) Stock | Price at $5.63, Up 6.03%Trade Ideas - UBND thành phố Hải Phòng
Sentiment Recap: What analysts say about Verastem Inc stockTrade Entry Report & AI Optimized Trade Strategies - baoquankhu1.vn
Verastem Oncology’s combo shows two-year durability in ovarian cancer - MSN
Fed Meeting: What is the Moat Score of Verastem IncQuarterly Earnings Report & Consistent Income Trade Recommendations - baoquankhu1.vn
Today's Analyst Rating Data for VSTM: Maintained Buy Rating | VS - GuruFocus
Today's Analyst Rating for VSTM: Maintains Buy Rating at $18.00 | VSTM Stock News - GuruFocus
Today's Analyst Rating for VSTM: Maintains Buy Rating at $18.00 - GuruFocus
Verastem stock maintains Buy rating at BTIG on durable trial data - Investing.com Canada
Verastem (NASDAQ:VSTM) Earns "Buy" Rating from BTIG Research - MarketBeat
Verastem (VSTM) Presents Positive Two-Year Data for Ovarian Canc - GuruFocus
Verastem’s cancer drug combo shows durability in 2-year data By Investing.com - Investing.com India
Verastem’s cancer drug combo shows durability in 2-year data - Investing.com
Verastem Oncology announces two-year median follow-up data on Avmapki® Fakzynja® combination therapy - marketscreener.com
Verastem Inc (VSTM) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):